Cargando…

Better Identification of Cognitive Decline With Interleukin-2 Than With Amyloid and Tau Protein Biomarkers in Amnestic Mild Cognitive Impairment

The rate of cognitive decline among patients with amnestic mild cognitive impairment (aMCI) varies, and it is thus crucial to accurately predict the probability of cognitive deterioration in patients with MCI. We compared the potential of cytokines with amyloid beta (Aβ) and tau biomarkers for predi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Chih-Sung, Tsai, Chia-Lin, Lin, Guan-Yu, Lee, Jiunn-Tay, Lin, Yu-Kai, Chu, Che-Sheng, Sung, Yueh-Feng, Tsai, Chia-Kuang, Yeh, Ta-Chuan, Chu, Hsuan-Te, Su, Ming-Wei, Yang, Fu-Chi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193360/ https://www.ncbi.nlm.nih.gov/pubmed/34122046 http://dx.doi.org/10.3389/fnagi.2021.670115

Ejemplares similares

Associations between Plasma Biomarkers and Cognition in Patients with Alzheimer’s Disease and Amnestic Mild Cognitive Impairment: A Cross-Sectional and Longitudinal Study
por: Tsai, Chia-Lin, et al.
Publicado: (2019)

A Metallomic Approach to Assess Associations of Plasma Metal Levels with Amnestic Mild Cognitive Impairment and Alzheimer’s Disease: An Exploratory Study
por: Lin, Yu-Kai, et al.
Publicado: (2022)

The role of interleukin-33 in patients with mild cognitive impairment and Alzheimer’s disease
por: Liang, Chih-Sung, et al.
Publicado: (2020)

Genetic Variants Associated With Subjective Cognitive Decline in Patients With Migraine
por: Yeh, Po-Kuan, et al.
Publicado: (2022)

Plasma Aβ42 and Total Tau Predict Cognitive Decline in Amnestic Mild Cognitive Impairment
por: Chen, Ting-Bin, et al.
Publicado: (2019)

Visual cognition in non-amnestic Alzheimer's disease: Relations to tau, amyloid, and cortical atrophy
por: Putcha, Deepti, et al.
Publicado: (2019)

Cerebral amyloid deposition predicts long‐term cognitive decline in hemorrhagic small vessel disease
por: Tsai, Ya‐Chin, et al.
Publicado: (2023)

Differential associations of visual memory with hippocampal subfields in subjective cognitive decline and amnestic mild cognitive impairment
por: Huang, Yanlu, et al.
Publicado: (2022)

Psychological stress, cognitive decline and the development of dementia in amnestic mild cognitive impairment
por: Sussams, Rebecca, et al.
Publicado: (2020)

Amyloid duration is associated with preclinical cognitive decline and tau PET
por: Koscik, Rebecca L., et al.
Publicado: (2020)

Identifying genetic variants for age of migraine onset in a Han Chinese population in Taiwan
por: Tsai, Chia-Kuang, et al.
Publicado: (2021)

Association of Suicide Risk With Headache Frequency Among Migraine Patients With and Without Aura
por: Lin, Yu-Kai, et al.
Publicado: (2019)

Shared alterations in hippocampal structural covariance in subjective cognitive decline and migraine
por: Tsai, Chia-Lin, et al.
Publicado: (2023)

Global-cognitive health metrics: A novel approach for assessing cognition impairment in adult population
por: Tsai, Chia-Kuang, et al.
Publicado: (2018)

Factors Predicting the Onset of Amnestic Mild Cognitive Impairment or Alzheimer’s Dementia in Persons With Subjective Cognitive Decline
por: Ahn, Sangwoo, et al.
Publicado: (2020)

Clinical Features of Cluster Headache: A Hospital-Based Study in Taiwan
por: Ko, Chien-An, et al.
Publicado: (2021)

Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline
por: Ossenkoppele, Rik, et al.
Publicado: (2022)

Reversal of Ophthalmic Artery Flow and Stroke Outcomes in Asian Patients with Acute Ischemic Stroke and Unilateral Severe Cervical Carotid Stenosis
por: Sung, Yueh-Feng, et al.
Publicado: (2013)

Associations between migraine occurrence and the effect of aura, age at onset, family history, and sex: A cross-sectional study
por: Hsu, Yu-Wei, et al.
Publicado: (2020)

Comparison of Amyloid Positivity Rate and Accumulation Pattern between Amnestic and Non-Amnestic Type Mild Cognitive Impairment
por: Lee, Sun Hyung, et al.
Publicado: (2020)

The impact of subthreshold levels of amyloid deposition on conversion to dementia in patients with amyloid-negative amnestic mild cognitive impairment
por: Kim, Hyung-Ji, et al.
Publicado: (2022)

Oh brother, where art tau? Amyloid, neurodegeneration, and cognitive decline without elevated tau
por: McCollum, Lauren E., et al.
Publicado: (2021)

Association of White Matter Hyperintensity Progression with Cognitive Decline in Patients with Amnestic Mild Cognitive Impairment
por: Hirao, Kentaro, et al.
Publicado: (2021)

Amyloid related cerebral microbleed and plasma Aβ40 are associated with cognitive decline in Parkinson’s disease
por: Tsai, Hsin-Hsi, et al.
Publicado: (2021)

Amyloid- β and tau deposition influences cognitive and functional decline in Down syndrome
por: Grigorova, Monika, et al.
Publicado: (2022)

Distinct Inflammation Biomarkers in Healthy Individuals and Patients with Schizophrenia: A Reliability Testing of Multiplex Cytokine Immunoassay by Bland-Altman Analysis
por: Yeh, Ta-Chuan, et al.
Publicado: (2019)

Baseline Neuroimaging Predicts Decline to Dementia From Amnestic Mild Cognitive Impairment
por: Gullett, Joseph M., et al.
Publicado: (2021)

Risk Factor Stratification for Intracranial Stenosis in Taiwanese Patients With Cervicocerebral Stenosis
por: Sung, Yueh‐Feng, et al.
Publicado: (2015)

Olfactory identification in subjective cognitive decline and mild cognitive impairment: Association with tau but not amyloid positron emission tomography
por: Risacher, Shannon L., et al.
Publicado: (2017)

Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age
por: Betthauser, Tobey J, et al.
Publicado: (2020)

Neuropsychology and neuroimaging profiles of amyloid-positive versus amyloid-negative amnestic mild cognitive impairment patients
por: Tomadesso, Clémence, et al.
Publicado: (2018)

Revisiting the link between cognitive decline and masticatory dysfunction
por: Lin, Chia-shu
Publicado: (2018)

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease
por: Pichet Binette, Alexa, et al.
Publicado: (2022)

Medicinal Herbs and Their Derived Ingredients Protect against Cognitive Decline in In Vivo Models of Alzheimer’s Disease
por: Tsai, Yueh-Ting, et al.
Publicado: (2022)

Functional Connectivity Changes Across the Spectrum of Subjective Cognitive Decline, Amnestic Mild Cognitive Impairment and Alzheimer’s Disease
por: Wang, Ziqi, et al.
Publicado: (2019)

Disrupted Patterns of Rich-Club and Diverse-Club Organizations in Subjective Cognitive Decline and Amnestic Mild Cognitive Impairment
por: Xue, Chen, et al.
Publicado: (2020)

Increased risk of cognitive impairment in patients with components of metabolic syndrome
por: Tsai, Chia-Kuang, et al.
Publicado: (2016)

Incongruent Expression of Brain-Derived Neurotrophic Factor and Cortisol in Schizophrenia: Results from a Randomized Controlled Trial of Laughter Intervention
por: Cheng, Shu-Li, et al.
Publicado: (2020)

The Effect of Clinical Characteristics and Subtypes on Amyloid Positivity in Patients with Amnestic Mild Cognitive Impairment
por: Kim, Jeong Yeon, et al.
Publicado: (2019)

Cingulate white matter mediates the effects of fecal Ruminococcus on neuropsychiatric symptoms in patients with amyloid-positive amnestic mild cognitive impairment
por: Hung, Chun-Che, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pqa02v3nvoku0s7b0o4g31rl3j